| Financial Results – Ind-AS | 
| Particulars | 3 months/ 6 months ended         (dd-mm-yyyy) | Year to date figures for current period ended                              (dd-mm-yyyy) | 
| A | Date of start of reporting period | 01-01-2024 | 01-04-2023 | 
| B | Date of end of reporting period | 31-03-2024 | 31-03-2024 | 
| C | Whether results are audited or unaudited | Audited | Audited | 
| D | Nature of report standalone or consolidated | Standalone | Standalone | 
| Part I | Blue color marked fields are non-mandatory.                                                                                                                                                                                For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | 
| 23 | Total Comprehensive Income for the period | -13.53 | 403.69 | 
| 24 | Total profit or loss, attributable to | 
|  | Profit or loss, attributable to owners of parent |  |  | 
|  | Total profit or loss, attributable to non-controlling interests |  |  | 
| 25 | Total Comprehensive income for the period attributable to | 
|  | Comprehensive income for the period attributable to owners of parent | 0 | 0 | 
|  | Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0 | 0 | 
| 26 | Details of equity share capital | 
|  | Paid-up equity share capital | 90 | 90 | 
|  | Face value of equity share capital | 10 | 10 | 
| 27 | Details of debt securities | 
| 28 | Reserves excluding revaluation reserve |  | -445.8 | 
| 29 | Earnings per share | 
| i | Earnings per equity share for continuing operations | 
|  | Basic earnings (loss) per share from continuing operations | -1.5 | -6.2 | 
|  | Diluted earnings (loss) per share from continuing operations | -1.5 | -6.2 | 
| ii | Earnings per equity share for discontinued operations | 
|  | Basic earnings (loss) per share from discontinued operations | 0 | 0 | 
|  | Diluted earnings (loss) per share from discontinued operations | 0 | 0 | 
| ii | Earnings per equity share | 
|  | Basic earnings (loss) per share from continuing and discontinued operations | -1.5 | -6.2 | 
|  | Diluted earnings (loss) per share from continuing and discontinued operations | -1.5 | -6.2 | 
| 30 | Debt equity ratio | 0 | 0 | 
| 31 | Debt service coverage ratio | 0 | 0 | 
| 32 | Interest service coverage ratio | 0 | 0 | 
| 33 | Disclosure of notes on financial results |  | 
| Statement of Asset and Liabilities | 
| Particulars | Current year ended        (dd-mm-yyyy) | 
| Date of start of reporting period | 01-04-2023 | 
| Date of end of reporting period | 31-03-2024 | 
| Whether results are audited or unaudited | Audited | 
| Nature of report standalone or consolidated | Standalone | 
|  | Assets | 
| 1 | Non-current assets | 
|  | Property, plant and equipment | 1802.34 | 
|  | Capital work-in-progress | 0 | 
|  | Investment property | 0 | 
|  | Goodwill | 0 | 
|  | Other intangible assets | 0 | 
|  | Intangible assets under development | 0 | 
|  | Biological assets other than bearer plants | 0 | 
|  | Investments accounted for using equity method | 0 | 
|  | Non-current financial assets | 
|  | Non-current investments | 0 | 
|  | Trade receivables, non-current | 0 | 
|  | Loans, non-current | 0 | 
|  | Other non-current financial assets | 0 | 
|  | Total non-current financial assets | 0 | 
|  | Deferred tax assets (net) | 0 | 
|  | Other non-current assets | 0 | 
|  | Total non-current assets | 1802.34 | 
| 2 | Current assets | 
|  | Inventories | 0 | 
|  | Current financial asset | 
|  | Current investments | 0 | 
|  | Trade receivables, current | 16.27 | 
|  | Cash and cash equivalents | 3.63 | 
|  | Bank balance other than cash and cash equivalents | 0 | 
|  | Loans, current | 0 | 
|  | Other current financial assets | 0 | 
|  | Total current financial assets | 19.9 | 
|  | Current tax assets (net) | 0 | 
|  | Other current assets | 1.33 | 
|  | Total current assets | 21.23 | 
| Statement of Asset and Liabilities | 
| Particulars | Current year ended        (dd-mm-yyyy) | 
| Date of start of reporting period | 01-04-2023 | 
| Date of end of reporting period | 31-03-2024 | 
| Whether results are audited or unaudited | Audited | 
| Nature of report standalone or consolidated | Standalone | 
| 3 | Non-current assets classified as held for sale |  | 
| 4 | Regulatory deferral account debit balances and related deferred tax Assets |  | 
|  | Total assets | 1823.57 | 
|  | Equity and liabilities | 
|  | Equity | 
|  | Equity attributable to owners of parent | 
|  | Equity share capital | 90 | 
|  | Other equity | -42.12 | 
|  | Total equity attributable to owners of parent | 47.88 | 
|  | Non controlling interest |  | 
|  | Total equity | 47.88 | 
|  | Liabilities | 
|  | Non-current liabilities | 
|  | Non-current financial liabilities | 
|  | Borrowings, non-current | 0 | 
|  | Trade payables, non-current | 0 | 
|  | Other non-current financial liabilities | 1125.21 | 
|  | Total non-current financial liabilities | 1125.21 | 
|  | Provisions, non-current | 0 | 
|  | Deferred tax liabilities (net) | 564.35 | 
|  | Deferred government grants, Non-current | 0 | 
|  | Other non-current liabilities | 0 | 
|  | Total non-current liabilities | 1689.56 | 
|  | Current liabilities | 
|  | Current financial liabilities | 
|  | Borrowings, current | 0 | 
|  | Trade payables, current | 0.03 | 
|  | Other current financial liabilities | 85.99 | 
|  | Total current financial liabilities | 86.02 | 
|  | Other current liabilities | 0.11 | 
|  | Provisions, current | 0 | 
|  | Current tax liabilities (Net) | 0 | 
|  | Deferred government grants, Current | 0 | 
|  | Total current liabilities | 86.13 | 
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0 | 
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0 | 
|  | Total liabilities | 1775.69 | 
|  | Total equity and liabilites | 1823.57 | 
|  | Disclosure of notes on assets and liabilities |  | 
| Cash flow statement, indirect | 
| Particulars | Year ended (dd-mm-yyyy) | 
| A | Date of start of reporting period | 01-04-2023 | 
| B | Date of end of reporting period | 31-03-2024 | 
| C | Whether results are audited or unaudited | Audited | 
| D | Nature of report standalone or consolidated | Standalone | 
| Part I | Blue color marked fields are non-mandatory. | 
|  | Statement of cash flows |  | 
|  | Cash flows from used in operating activities |  | 
|  | Profit before tax | -79.4 | 
|  | Adjustments for reconcile profit (loss) |  | 
|  | Adjustments for finance costs | 0 | 
|  | Adjustments for decrease (increase) in inventories | 0 | 
|  | Adjustments for decrease (increase) in trade receivables, current | 0 | 
|  | Adjustments for decrease (increase) in trade receivables, non-current | 0 | 
|  | Adjustments for decrease (increase) in other current assets | -5.32 | 
|  | Adjustments for decrease (increase) in other non-current assets | 0 | 
|  | Adjustments for other financial assets, non-current | 0 | 
|  | Adjustments for other financial assets, current | 0 | 
|  | Adjustments for other bank balances | 0 | 
|  | Adjustments for increase (decrease) in trade payables, current | 0 | 
|  | Adjustments for increase (decrease) in trade payables, non-current | 0 | 
|  | Adjustments for increase (decrease) in other current liabilities | 0.14 | 
|  | Adjustments for increase (decrease) in other non-current liabilities | 0 | 
|  | Adjustments for depreciation and amortisation expense | 0 | 
|  | Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | 
|  | Adjustments for provisions, current | 0 | 
|  | Adjustments for provisions, non-current | 0 | 
|  | Adjustments for other financial liabilities, current | 12.51 | 
|  | Adjustments for other financial liabilities, non-current | 74.8 | 
|  | Adjustments for unrealised foreign exchange losses gains | 0 | 
|  | Adjustments for dividend income | 0 | 
|  | Adjustments for interest income | 0 | 
|  | Adjustments for share-based payments | 0 | 
|  | Adjustments for fair value losses (gains) | 0 | 
|  | Adjustments for undistributed profits of associates | 0 | 
|  | Other adjustments for which cash effects are investing or financing cash flow | 0 | 
|  | Other adjustments to reconcile profit (loss) | 0 | 
|  | Other adjustments for non-cash items | 0 | 
|  | Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | 
|  | Total adjustments for reconcile profit (loss) | 82.13 | 
|  | Net cash flows from (used in) operations | 2.73 | 
|  | Dividends received | 0 | 
|  | Interest paid | 0 | 
|  | Interest received | 0 | 
|  | Income taxes paid (refund) | 0 | 
|  | Other inflows (outflows) of cash | 0 | 
|  | Net cash flows from (used in) operating activities | 2.73 | 
|  | Cash flows from used in investing activities |  | 
|  | Cash flows from losing control of subsidiaries or other businesses | 0 | 
|  | Cash flows used in obtaining control of subsidiaries or other businesses | 0 | 
|  | Other cash receipts from sales of equity or debt instruments of other entities | 0 | 
|  | Other cash payments to acquire equity or debt instruments of other entities | 0 | 
|  | Other cash receipts from sales of interests in joint ventures | 0 | 
|  | Other cash payments to acquire interests in joint ventures | 0 | 
|  | Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | 
|  | Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | 
|  | Proceeds from sales of property, plant and equipment | 0 | 
|  | Purchase of property, plant and equipment | 0 | 
|  | Proceeds from sales of investment property | 0 | 
|  | Purchase of investment property | 0 | 
|  | Proceeds from sales of intangible assets | 0 | 
|  | Purchase of intangible assets | 0 | 
|  | Proceeds from sales of intangible assets under development | 0 | 
|  | Purchase of intangible assets under development | 0 | 
|  | Proceeds from sales of goodwill | 0 | 
|  | Purchase of goodwill | 0 | 
|  | Proceeds from biological assets other than bearer plants | 0 | 
|  | Purchase of biological assets other than bearer plants | 0 | 
|  | Proceeds from government grants | 0 | 
|  | Proceeds from sales of other long-term assets | 0 | 
|  | Purchase of other long-term assets | 0 | 
|  | Cash advances and loans made to other parties | 0 | 
|  | Cash receipts from repayment of advances and loans made to other parties | 0 | 
|  | Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | 
|  | Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | 
|  | Dividends received | 0 | 
|  | Interest received | 0 | 
|  | Income taxes paid (refund) | 0 | 
|  | Other inflows (outflows) of cash | 0 | 
|  | Net cash flows from (used in) investing activities | 0 | 
|  | Cash flows from used in financing activities |  | 
|  | Proceeds from changes in ownership interests in subsidiaries | 0 | 
|  | Payments from changes in ownership interests in subsidiaries | 0 | 
|  | Proceeds from issuing shares | 0 | 
|  | Proceeds from issuing other equity instruments | 0 | 
|  | Payments to acquire or redeem entity's shares | 0 | 
|  | Payments of other equity instruments | 0 | 
|  | Proceeds from exercise of stock options | 0 | 
|  | Proceeds from issuing debentures notes bonds etc | 0 | 
|  | Proceeds from borrowings | 0 | 
|  | Repayments of borrowings | 0 | 
|  | Payments of finance lease liabilities | 0 | 
|  | Payments of lease liabilities | 0 | 
|  | Dividends paid | 0 | 
|  | Interest paid | 0 | 
|  | Income taxes paid (refund) | 0 | 
|  | Other inflows (outflows) of cash | 0 | 
|  | Net cash flows from (used in) financing activities | 0 | 
|  | Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 2.73 | 
|  | Effect of exchange rate changes on cash and cash equivalents |  | 
|  | Effect of exchange rate changes on cash and cash equivalents | 0 | 
|  | Net increase (decrease) in cash and cash equivalents | 2.73 | 
|  | Cash and cash equivalents cash flow statement at beginning of period | 0.9 | 
|  | Cash and cash equivalents cash flow statement at end of period | 3.63 |